UK-based CBD brand Naturecan acquires Oregon production facility
United Kingdom-based CBD and wellness brand Naturecan acquired the IAH Oregon cannabidiol production facility in the U.S. for 8 million pounds (roughly $10 million).
Cannabis vape hardware firm Greentank raises $16.5 million
Vape hardware manufacturer Greentank Technologies closed a Series B financing round worth $16.5 million with an unspecified “strategic investor group” that includes Canadian cannabis producer Organigram Holdings.
Canadian cannabis industry reckons with inflated THC label claims
Potency testing on store-bought cannabis flower by a Canadian laboratory has found THC levels significantly lower than the labeled value, sparking an industrywide conversation about how to address inaccurate THC claims.
Synthetic cannabinoids further rift between marijuana and hemp industries
A recent ruling from the U.S. Drug Enforcement Administration classifying a synthetic cannabinoid as a Schedule 1 drug has furthered the ire between the licensed cannabis industry and the largely unregulated cannabinoid sector, which has grown into a multi-billion market amid the proliferation of CBD and Delta-lineage products since the passage of the 2018 Farm Bill.
These marijuana companies are doubling down on California
While some marijuana companies are exiting California’s difficult, regulated market – Curaleaf Holdings is among the most notable – others big and small are staying focused on the state and have plans to grow in 2023.
Bids stall to restrict high-THC products in Washington state
Efforts to cap the potency of cannabis products in Washington state and limit high-potency THC to the medical marijuana market appear to have failed.
Canadian cannabis company Adastra gets permission to sell cocaine
British Columbia-based cannabis company Adastra Labs has been approved by Health Canada to possess, produce, sell and distribute cocaine, psilocybin and psilocin.
